BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11135592)

  • 1. FDA uneasy about placebo revision.
    Hollon T
    Nat Med; 2001 Jan; 7(1):7. PubMed ID: 11135592
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethics. Clinical trials guidelines at odds with U.S. policy.
    Normile D
    Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510
    [No Abstract]   [Full Text] [Related]  

  • 3. Another meeting on the Helsinki Declaration.
    Bull Med Ethics; 2001 Mar; (166):13-4. PubMed ID: 11878333
    [No Abstract]   [Full Text] [Related]  

  • 4. Trials on trial.
    Nature; 2008 May; 453(7194):427-8. PubMed ID: 18497763
    [No Abstract]   [Full Text] [Related]  

  • 5. [The ethical dilemma of placebos].
    Agostoni A
    Recenti Prog Med; 2000 Nov; 91(11):549-51. PubMed ID: 11125945
    [No Abstract]   [Full Text] [Related]  

  • 6. Does the FDA have the authority to trump the Declaration of Helsinki?
    Goodyear MD; Lemmens T; Sprumont D; Tangwa G
    BMJ; 2009 Apr; 338():b1559. PubMed ID: 19383751
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is the placebo still ethically acceptable and scientifically useful in clinical drug experimentation?].
    Mariani L; Ventresca GP
    Clin Ter; 1996 Nov; 147(11):595-8. PubMed ID: 9264914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 9. The monopoly stage of capitalism.
    Nicholson RH
    Hastings Cent Rep; 2001; 31(3):8. PubMed ID: 11478126
    [No Abstract]   [Full Text] [Related]  

  • 10. Human subject protection; foreign clinical studies not conducted under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Apr; 73(82):22800-16. PubMed ID: 18567164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA tightens human oversight.
    Dove A
    Nat Med; 2001 Jun; 7(6):646. PubMed ID: 11385485
    [No Abstract]   [Full Text] [Related]  

  • 12. Placebo-controlled trials and the Declaration of Helsinki.
    Lewis JA; Jonsson B; Kreutz G; Sampaio C; van Zwieten-Boot B
    Lancet; 2002 Apr; 359(9314):1337-40. PubMed ID: 11965296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helsinki redux.
    Reider B
    Am J Sports Med; 2015 Apr; 43(4):791-3. PubMed ID: 25829073
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA slow to encourage lupus drugs.
    Webber D
    Nat Biotechnol; 1999 Apr; 17(4):319. PubMed ID: 10207867
    [No Abstract]   [Full Text] [Related]  

  • 15. The FDA and Helsinki.
    Rennie S
    Hastings Cent Rep; 2009; 39(3):49. PubMed ID: 19537622
    [No Abstract]   [Full Text] [Related]  

  • 16. Research involving human subjects in developing countries.
    Koski G; Nightingale SL
    N Engl J Med; 2001 Jul; 345(2):136-8. PubMed ID: 11450664
    [No Abstract]   [Full Text] [Related]  

  • 17. The Declaration of Helsinki and research in vulnerable populations.
    Denholm JT
    Med J Aust; 2000 Aug; 173(4):223-4. PubMed ID: 11008603
    [No Abstract]   [Full Text] [Related]  

  • 18. US exceptionalism comes to research ethics.
    Lurie P; Greco DB
    Lancet; 2005 Mar 26-Apr 1; 365(9465):1117-9. PubMed ID: 15794954
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient group seeks overhaul of FDA clinical trial system in court.
    Hede K
    J Natl Cancer Inst; 2006 Sep; 98(18):1268-70. PubMed ID: 16985242
    [No Abstract]   [Full Text] [Related]  

  • 20. The placebo: promise and compromise.
    Regan J; Hamer G; Wright A; Armour A; Fu J
    Tenn Med; 2005 Mar; 98(3):138-9. PubMed ID: 15974105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.